Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Study of Bleeding With Extended Administration of an Oral Contraceptive

ClinicalTrials.gov ID: NCT00338052

Public ClinicalTrials.gov record NCT00338052. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label Study of Cycle Control With Extended Administration of Norethindrone Acetate 1 mg / Ethinyl Estradiol 20 Mcg Oral Tablets

Study identification

NCT ID
NCT00338052
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Warner Chilcott
Industry
Enrollment
207 participants

Conditions and interventions

Conditions

Interventions

  • Norethindrone 1 mg / ethinyl estradiol 20 mcg Drug

Drug

Eligibility (public fields only)

Age range
25 Years to 40 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
May 7, 2008

2006 – 2007

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Warner Chilcott Investigational Site Phoenix Arizona 85031
Warner Chilcott Investigational Site Phoenix Arizona 85050
Warner Chilcott Investigational Site Tempe Arizona 85283
Warner Chilcott Investigational Site Carmichael California 95608
Warner Chilcott Investigational Site Boynton Beach Florida 33437
Warner Chilcott Investigational Site Leesburg Florida 34748
Warner Chilcott Investigational Site Miami Florida 33143
Warner Chilcott Investigational Site Miami Florida 33186
Warner Chilcott Investigational Site West Palm Beach Florida 33401
Warner Chilcott Investigational Site Decatur Georgia 30034
Warner Chilcott Investigational Site Roswell Georgia 30075
Warner Chilcott Investigational Site Peoria Illinois 61615
Warner Chilcott Investigational Site Lexington Kentucky 40509
Warner Chilcott Investigational Site Louisville Kentucky 40291
Warner Chilcott Investigational Site New Bern North Carolina 28562
Warner Chilcott Investigational Site Winston-Salem North Carolina 27103
Warner Chilcott Investigational Site Philadelphia Pennsylvania 19114
Warner Chilcott Investigational Site Greenville South Carolina 29607
Warner Chilcott Investigational Site Pleasant Grove Utah 84062
Warner Chilcott Investigational Site Salt Lake City Utah 84017
Warner Chilcott Investigational Site Sandy City Utah 84070
Warner Chilcott Investigational Site Virginia Beach Virginia 23456
Warner Chilcott Investigational Site Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00338052, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2008 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00338052 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →